NYSEMKT: NRXSNeuraxis Inc Stock
$3.21-0.09 (-2.73%)
Updated May 3, 2024
NRXS Price
$3.21
Fair Value Price
N/A
Market Cap
$21.17M
52 Week Low
$1.80
52 Week High
$6.93
P/E
-0.71x
P/B
-15.09x
P/S
3.53x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.46M
Earnings
-$14.63M
Gross Margin
87.7%
Operating Margin
-575.2%
Profit Margin
-594.6%
Debt to Equity
-1.36
Operating Cash Flow
-$7M
Beta
1.5
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NRXS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NRXS is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NRXS is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
NRXS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more NRXS due diligence checks available for Premium users.
Be the first to know about important NRXS news, forecast changes, insider trades & much more!
NRXS News
Valuation
NRXS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.71x
Industry
27.79x
Market
35.94x
NRXS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-15.09x
Industry
3.71x
NRXS's financial health
Profit margin
Revenue
$531.5k
Net Income
-$5.3M
Profit Margin
-999.8%
NRXS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NRXS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$509.5k
Liabilities
$1.9M
Debt to equity
-1.36
NRXS's short-term liabilities ($1.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NRXS's short-term assets ($242.61k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NRXS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NRXS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.6M
Investing
-$16.0k
Financing
$2.0M
NRXS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
NRXS vs Medical Device Stocks
Neuraxis Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.